IL1B and viral infectious disease: In a randomized placebo controlled human study conducted by Arts et al. [25], it was evident that BCG vaccine induces genetic reprogramming of monocytes and shown protection against few experimental viral infections with an underlying key role of interleukin-1 beta (IL-1β) as a trained immune response.